Non-alcoholic fatty liver disease (NAFLD): a significant predictor of gestational diabetes mellitus (GDM) and early pregnancy miscarriages—prospective study in Rajarata Pregnancy Cohort (RaPCo)
2022; BMJ; Volume: 9; Issue: 1 Linguagem: Inglês
10.1136/bmjgast-2021-000831
ISSN2054-4774
AutoresIresha Sandamali Koralegedara, Janith Warnasekara, Korale Gedara Dayaratne, Farika Nirmani de Silva, Jagath Premadasa, Suneth Agampodi,
Tópico(s)Diet, Metabolism, and Disease
ResumoNon-alcoholic fatty liver disease (NAFLD) is increasing globally with a mounting body of evidence on various adverse effects on pregnancy. Yet, prospective studies, especially from low-income and middle-income countries, are lacking in examining the impact of NAFLD in pregnancy. In this study, we explored the effect of NAFLD on the development of gestational diabetes mellitus (GDM) and early pregnancy miscarriages.
Referência(s)